Screening for late-onset gestational diabetes: Are there any clinical benefits?

Objective: To determine whether screening for gestational diabetes mellitus (GDM) in the third trimester and managing those who are screen positive on a diabetes pathway affects obstetric and neonatal outcomes.

Design: Retrospective study of prospectively collected data.

Setting: London Teaching Hospital.